PBIO (Pressure BioSciences) LT-Debt-to-Total-Asset: 0.08 (As of Jun. 2024)


PBIO Pressure BioSciences Inc PBIO
12 GF Score
Price $0.00
View Full Analysis

What is Pressure BioSciences LT-Debt-to-Total-Asset?

Pressure BioSciences PBIO -71.43% 12 LT-Debt-to-Total-Asset is 0.08 as of Jun. 2024. GuruFocus rates PBIO with a GF Score™ of 12/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Pressure BioSciences's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.08.

Pressure BioSciences's long-term debt to total assets ratio declined from Jun. 2023 (0.15) to Jun. 2024 (0.08). It may suggest that Pressure BioSciences is progressively becoming less dependent on debt to grow their business.

Pressure BioSciences  (OTCPK:PBIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Pressure BioSciences LT-Debt-to-Total-Asset Related Terms

Pressure BioSciences LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Pressure BioSciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences LT-Debt-to-Total-Asset Chart

Pressure BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.30 0.15 0.14 0.21

Pressure BioSciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.21 0.08 0.08
PBIO
12GF Score
Pressure BioSciences Inc PBIO
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pressure BioSciences LT-Debt-to-Total-Asset Calculation

Pressure BioSciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=0.223/1.05
=0.21

Pressure BioSciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )/Total Assets (Q: Jun. 2024 )
=0.519/6.879
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.08 mean?
Pressure BioSciences (PBIO) has a LT-Debt-to-Total-Asset of 0.08 as of Jun. 2024. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Pressure BioSciences and its competitors.
Is Pressure BioSciences' LT-Debt-to-Total-Asset too high?
Pressure BioSciences' current LT-Debt-to-Total-Asset is 0.08. Overall, Pressure BioSciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pressure BioSciences' LT-Debt-to-Total-Asset compare to EMED and CUTRQ?
Pressure BioSciences' LT-Debt-to-Total-Asset of 0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Pressure BioSciences and its competitors. Pressure BioSciences's current LT-Debt-to-Total-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pressure BioSciences stock overvalued right now?
Pressure BioSciences (PBIO) has a current LT-Debt-to-Total-Asset of 0.08. The current LT-Debt-to-Total-Asset is 0.08. Pressure BioSciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Pressure BioSciences (PBIO), the current LT-Debt-to-Total-Asset is 0.08 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pressure BioSciences Business Description

Address 14 Norfolk Avenue, South Easton, MA, USA, 02375
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
12GF Score

Get the complete analysis for PBIO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price